Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-17-000722
Filing Date
2017-09-26
Accepted
2017-09-26 18:37:48
Documents
1
Period of Report
2017-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4050
  Complete submission text file 0001012975-17-000722.txt   5554
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 FIRSTFIELD RD., SUITE 200 GAITHERSBURG MD 20878
Business Address
Tasker Sybil (Reporting) CIK: 0001705900 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 171102947